CoreFirst Bank & Trust’s Elevance Health ELV Stock Holding History

CoreFirst Bank & Trust’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.51K	Hold	12	–	–	﹤0.01%	285
2025 Q4	$4.21K	Hold	12	–	–	﹤0.01%	292
2025 Q3	$3.88K	Hold	12	–	–	﹤0.01%	319
2025 Q2	$4.67K	Buy	+12	New	+$4.83K	﹤0.01%	322
2025 Q1	–	Sell	-12	Closed	-$4.43K	–	178
2024 Q4	$4.43K	Hold	12	–	–	﹤0.01%	337
2024 Q3	$6.24K	Buy	+12	New	+$6.41K	﹤0.01%	317
2024 Q2	–	Sell	-12	Closed	-$6.22K	–	187
2024 Q1	$6.22K	Hold	12	–	–	﹤0.01%	324
2023 Q4	$5.66K	Hold	12	–	–	﹤0.01%	334
2023 Q3	$5.22K	Buy	+12	New	+$5.44K	﹤0.01%	357

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

CoreFirst Bank & Trust's ELV Position: Q1 2026 in Review

CoreFirst Bank & Trust held its Elevance Health (ELV) position steady in Q1 2026 at 12 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

CoreFirst Bank & Trust first reported a position in ELV in Q3 2023 and has held it in 9 quarters since. The position peaked at $6.24K in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

CoreFirst Bank & Trust held 12 shares of Elevance Health worth $3.51K as of Q1 2026.
CoreFirst Bank & Trust left its Elevance Health share count unchanged in Q1 2026.
Elevance Health made up ﹤0.01% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #285 holding.
CoreFirst Bank & Trust first reported a position in Elevance Health in Q3 2023 and has held it in 9 quarters since.
CoreFirst Bank & Trust's Elevance Health position peaked at $6.24K in Q3 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.